|
|
|
Volumn 145, Issue 9, 2001, Pages 75-82
|
|
Novel antipsychotic drugs in the management of schizophrenia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBAMAZEPINE;
CIMETIDINE;
CIPROFLOXACIN;
CLARITHROMYCIN;
CLOZAPINE;
CYTOCHROME P450 INHIBITOR;
DOPAMINE 2 RECEPTOR BLOCKING AGENT;
ENOXACIN;
ENZYME INDUCING AGENT;
ERYTHROMYCIN;
ETHOSUXIMIDE;
FLUOXETINE;
FLUVOXAMINE;
GATIFLOXACIN;
ISONIAZID;
NEUROLEPTIC AGENT;
NORFLOXACIN;
OLANZAPINE;
PAROXETINE;
PHENOBARBITAL;
PHENYTOIN;
QUETIAPINE;
RIFAMPICIN;
RISPERIDONE;
SEROTONIN 2 ANTAGONIST;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNINDEXED DRUG;
ZILEUTON;
ZIPRASIDONE;
AGRANULOCYTOSIS;
BODY WEIGHT DISORDER;
CATARACT;
CLINICAL TRIAL;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG DOSAGE FORM;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG TOLERABILITY;
HUMAN;
META ANALYSIS;
PATIENT COMPLIANCE;
REVIEW;
SCHIZOPHRENIA;
TARDIVE DYSKINESIA;
TERATOGENICITY;
TORSADE DES POINTES;
|
|
EID: 0035821085
PISSN: 00126616
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|
